PMID- 21063237 OWN - NLM STAT- MEDLINE DCOM- 20110729 LR - 20110421 IS - 1473-5873 (Electronic) IS - 0955-8829 (Linking) VI - 21 IP - 3 DP - 2011 Jun TI - Effect of ADRA2A and BDNF gene-gene interaction on the continuous performance test phenotype. PG - 132-5 LID - 10.1097/YPG.0b013e328341a389 [doi] AB - Complex phenotypes such as performance on the continuous performance test (CPT) are likely to exhibit epistasis. Genetic polymorphisms of noradrenergic system and brain-derived neurotrophic factor (BDNF), which participates in the differentiation and survival of noradrenergic neurons, have been reported to be associated with the performance on CPT. We evaluated the effect of the adrenergic alpha-2A receptor (ADRA2A) and BDNF gene-gene interaction on performance on the CPT in a Korean population with attention-deficit/hyperactivity disorder. In all, 122 participants with attention-deficit/hyperactivity disorder (8.6+/-2.3 years, 104 boys and 18 girls) completed the CPT. The DraI polymorphism of ADRA2A (rs583668) and rs11030101 polymorphism of BDNF were genotyped. Significant interaction effect was found of ADRA2A rs553668 and BDNF rs11030101 on response time variability (P=0.011) of the CPT. Our study provides preliminary evidence for the effect of the BDNF and ADRA2A gene-gene interaction on performance on the CPT in attention-deficit/hyperactivity disorder. FAU - Cho, Soo-Churl AU - Cho SC AD - Division of Child and Adolescent Psychiatry, Department of Neuropsychiatry, Seoul National University College of Medicine, Korea. FAU - Kim, Jae-Won AU - Kim JW FAU - Kim, Hyo-Won AU - Kim HW FAU - Kim, Boong-Nyun AU - Kim BN FAU - Shin, Min-Sup AU - Shin MS FAU - Cho, Dae-Yeon AU - Cho DY FAU - Jung, Sun-Woo AU - Jung SW FAU - Chung, Un-Sun AU - Chung US FAU - Son, Jung-Woo AU - Son JW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Psychiatr Genet JT - Psychiatric genetics JID - 9106748 RN - 0 (ADRA2A protein, human) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (DNA Primers) RN - 0 (Receptors, Adrenergic, alpha-2) SB - IM MH - Attention Deficit Disorder with Hyperactivity/*genetics MH - Base Sequence MH - Brain-Derived Neurotrophic Factor/*genetics MH - Child MH - DNA Primers MH - *Epistasis, Genetic MH - Female MH - Humans MH - Male MH - Phenotype MH - Receptors, Adrenergic, alpha-2/*genetics EDAT- 2010/11/11 06:00 MHDA- 2011/07/30 06:00 CRDT- 2010/11/11 06:00 PHST- 2010/11/11 06:00 [entrez] PHST- 2010/11/11 06:00 [pubmed] PHST- 2011/07/30 06:00 [medline] AID - 10.1097/YPG.0b013e328341a389 [doi] PST - ppublish SO - Psychiatr Genet. 2011 Jun;21(3):132-5. doi: 10.1097/YPG.0b013e328341a389.